000 | 01981 a2200517 4500 | ||
---|---|---|---|
005 | 20250518072302.0 | ||
264 | 0 | _c20210427 | |
008 | 202104s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1093/cid/ciz1149 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWolf, Joshua | |
245 | 0 | 0 |
_aSafety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE). _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _c12 2020 |
||
300 |
_a2581-2588 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAminoglycosides _xadverse effects |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClostridioides |
650 | 0 | 4 | _aClostridioides difficile |
650 | 0 | 4 | _aClostridium |
650 | 0 | 4 |
_aClostridium Infections _xdrug therapy |
650 | 0 | 4 | _aFidaxomicin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVancomycin _xadverse effects |
700 | 1 | _aKalocsai, Krisztina | |
700 | 1 | _aFortuny, Claudia | |
700 | 1 | _aLazar, Stefan | |
700 | 1 | _aBosis, Samantha | |
700 | 1 | _aKorczowski, Bartosz | |
700 | 1 | _aPetit, Arnaud | |
700 | 1 | _aBradford, Daniel | |
700 | 1 | _aCroos-Dabrera, Rodney | |
700 | 1 | _aIncera, Elodie | |
700 | 1 | _aMelis, Joost | |
700 | 1 | _avan Maanen, Rob | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 71 _gno. 10 _gp. 2581-2588 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciz1149 _zAvailable from publisher's website |
999 |
_c30357841 _d30357841 |